Cordyceps Sunshine Biotech Holdings Co., Ltd. (RAJAF) Operating cash flow 2021–2025
Cordyceps Sunshine Biotech Holdings Co., Ltd. (RAJAF) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$35,845FY2025 · since FY2021: -$365,363 → -$35,845
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$35,845 | -111.5% |
| FY2024 | $312,006 | -13.3% |
| FY2023 | $359,724 | +211.9% |
| FY2022 | -$321,378 | +12.0% |
| FY2021 | -$365,363 | — |
Source: SEC XBRL filings · For reference only · Not investment advice